Эдуард Авербух

Научные публикации

• Cortical Visual Mapping following Ocular Gene Augmentation Therapy for Achromatopsia
• Endogenous fungal endophthalmitis: risk factors, clinical course, and visual outcome in 13 patients
• Naturally-occurring myopia and loss of cone function in a sheep model of achromatopsia
• Correlation of Response between Both Eyes to First- and Second-Line Anti-VEGF Therapy in Diabetic Macular Edema
• Evaluation of Photoreceptor Transduction Efficacy of Capsid-Modified Adeno-Associated Viral Vectors Following Intravitreal and Subretinal Delivery in Sheep
• Socioeconomic status and visual outcome in patients with neovascular age-related macular degeneration
• PERSISTENT LOCULATED SUBRETINAL FLUID AFTER RHEGMATOGENOUS RETINAL DETACHMENT SURGERY
• Consecutive unilateral recording of the two eyes affects dark-adapted ERG responses, when compared to simultaneous bilateral recording
• Six Years and Counting: Restoration of Photopic Retinal Function and Visual Behavior Following Gene Augmentation Therapy in a Sheep Model of CNGA3 Achromatopsia
• Safety and Efficacy Evaluation of rAAV2tYF-PR1.7-hCNGA3 Vector Delivered by Subretinal Injection in CNGA3 Mutant Achromatopsia Sheep
• Gene Augmentation Therapy for a Missense Substitution in the cGMP-Binding Domain of Ovine CNGA3 Gene Restores Vision in Day-Blind Sheep
• Evaluation of the association of single nucleotide polymorphisms in the PRPH2 gene with adult-onset foveomacular vitelliform dystrophy
• Characterising the phenotype and progression of sporadic adult-onset foveomacular vitelliform dystrophy
• Gene Augmentation Therapy Restores Retinal Function and Visual Behavior in a Sheep Model of CNGA3 Achromatopsia
• Bevacizumab treatment for neovascular age-related macular degeneration in the setting of a clinic: "real life" long-term outcome
• Flicker cone function in normal and day blind sheep: a large animal model for human achromatopsia caused by CNGA3 mutation
• Bevacizumab treatment for choroidal neovascularization associated with adult-onset foveomacular vitelliform dystrophy
• Association of pattern dystrophy with an HTRA1 single-nucleotide polymorphism
• Bevacizumab for choroidal neovascularization related to inflammatory diseases
• Irido-cilio-choroidal melanoma in a 5-year-old boy treated by Ru-106 brachytherapy
• A novel day blindness in sheep: epidemiological, behavioural, electrophysiological and histopathological studies
• Sequence variants in HTRA1 and LOC387715/ARMS2 and phenotype and response to photodynamic therapy in neovascular age-related macular degeneration in populations from Israel
• Association of complement factor H Y402H polymorphism with phenotype of neovascular age related macular degeneration in Israel
• A novel de novo PAX6 mutation in an Ashkenazi-Jewish family with aniridia
• Application of the standard photodynamic treatment protocol for symptomatic circumscribed choroidal hemangioma
• Diabetic macular edema: towards therapy aimed at the underlying pathogenic mechanisms
• Treatment of ocular tissues exposed to nitrogen mustard: beneficial effect of zinc desferrioxamine combined with steroids
• The evidence supporting the early treatment for type 1 retinopathy of prematurity needs further evaluation
• Traumatic pediatric retinal detachment: a comparison between open and closed globe injuries
• Bilateral iridociliary T-cell lymphoma